Baseimmune a London based biotech leveraging deep learning AI to predict pathogen mutations for vaccine development has raised $11 3M approximately €10 40M in a Series A funding round The investment was led by new investors MSD Global Health Innovation Fund and IQ Capital with participation from existing backers such